What scientists know so far
We provide these clinician-guided programs through in-person appointments at our physical clinics as well as secure virtual telehealth visits for residents throughout Oregon, Washington, and California
The trial involving 18,000 people not yet published as of September 2023 is apparently the first to show that GLP-1 drugs can confer heart health benefits for people who are overweight but don't have diabetes
The MHRA and EMA continuously monitor the safety of these medications, and patients are encouraged to report suspected side effects via the MHRA Yellow Card scheme
Despite high demand for the new generation of weight loss drugs, they currently face numerous commercial insurance coverage restrictions
Because Tirzepatide is so large, it is very difficult for it to cross the biological barriers into your milk ducts